Herpes simplex virus types 1 and 2 HSV1 and 2, namely varicella-zoster VZV and
cytomegalovirus CMV, are among the most common pathogens worldwide. They remain in …

The current prevention efforts for STIs, HIV and viral hepatitis in the WHO European Region,
especially in the Central and Eastern subregions, are hindered by healthcare disparities …

HSV-1 causes 50% of first-time genital herpes infections in resource-rich countries and
affects 190 million people worldwide. A prophylactic herpes vaccine is needed to protect …

Nucleoside-modified mRNA vaccines have gained global attention because of COVID-19.
We evaluated a similar vaccine approach for preventing a chronic, latent genital infection …

This review examines the recent literature on the management of herpes simplex virus
(HSV) infections in neonates. We summarized the three clinical categories of maternal HSV …

Herpesviruses establish latent infections, and most reactivate frequently, resulting in
symptoms and virus shedding in healthy individuals. In immunocompromised patients …

Genital herpes, primarily caused by herpes simplex virus-2 (HSV-2), remains a pressing
global health concern. Its remarkable ability to intertwine with cellular processes, from …

Herpes simplex virus (HSV) infections are among the most common viral infections and
usually last for a lifetime. The virus can potentially be controlled with vaccines since humans …

The fetal/neonatal period represents both a unique window of opportunity for interventions
as well as vulnerability to a number of viral infections. While Herpesviruses such as herpes …

Herpes simplex virus (HSV), an epidemic human pathogen threatening global public health,
gains notoriety for its complex pathogenesis that encompasses lytic infection of mucosal …